Why The Biotech With The First Testable COVID-19 Vaccine Is A “Pronto” Sell
This biotech firm has the first testable vaccine for the novel coronavirus, but the author of today’s article argues that “If you’re looking for massive…
This biotech firm has the first testable vaccine for the novel coronavirus, but the author of today’s article argues that “If you’re looking for massive…
As the number of those infected with COVID-19 goes up domestically and globally, the competition to develop a vaccine is heating up – and the…
No matter what happens to the economy, people aren’t going to stop taking their prescription medications. As a result, the author of today’s article suggests…
While some are clearly being hit harder than others, every sector is being impacted to some extent by the widespread disruptions caused by the coronavirus…
While the stock highlighted in today’s article is, like most, down significantly this year, it has risen in recent days – and one trader believes…
In recent days, the stock market has experienced both its worst – and best – days in decades, leading the author of today’s article to…
While the authors of today’s article are stock pickers, they argue that there are some situations where exchange-traded funds are the better option – and…
The “indiscriminate selling” that has taken place over the past month has created an opportunity for investors to “practically steal” a large number of quality…
When it comes to the violent swings experienced by the stock market over the last few weeks, the author of today’s article points out that…
In volatile times such as these, investors tend to seek refuge in so-called safe-haven assets such as U.S. Treasury bonds and precious metals. As the…